NCT05108298 2026-03-02
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
Clinical Trials
12 trialsNCT07148245 2025-11-10
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
University of California, San Francisco
Recruiting
NCT00591500 2025-08-03
A Model for Genetic Susceptibility: Melanoma
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT01624220 2023-12-05
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
Phase NA Completed
NCT04675346 2022-11-22
EUNASS
Oxford University Hospitals NHS Trust
Completed
NCT04698161 2022-08-04
BIOMIS-Onco
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Completed
NCT03518814 2018-07-19
QUALM
Lille Catholic University
Completed
NCT00495950 2016-11-25
Prospective Measurement of Post-Treatment Lymphedema
M.D. Anderson Cancer Center
Completed
NCT01356771 2016-08-19
PennSCAPE
University of Pennsylvania
Phase NA Completed
NCT00518050 2015-07-16
Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
Memorial Sloan Kettering Cancer Center
Completed
NCT01193036 2015-01-08
Symptom Burden in Patients With Cancer- and Treatment-Related Skin Problems
M.D. Anderson Cancer Center
Terminated
NCT00816374 2014-05-16
Tailored Intervention for Melanoma Patient's Families
Fox Chase Cancer Center
Phase NA Completed